## **Financial Statements** 

## **for the Year Ended 31 December 2025** 

**for Great Aycliffe Cancer Charity** 

**Charity No 1188444** 



## **Great Aycliffe Cancer Support** 

## **Contents of the Financial Statements for the Year Ended 31 December 2025** 

||**Page**||
|---|---|---|
|**Legal & Administrative Information**||1|
|**Report of the Trustees**||2|
|**Independent Examiner’s Report**||3|
|**Statement of Financial Activities**||4|
|**Balance Sheet**||5|
|**Notes to the Financial Statements**||6 - 8|





## **Great Aycliffe Cancer Support** 

## **Legal and Administrative Information for the Year Ended 31 December 2025** 

**TRUSTEES:** A White V Moody D Morris A Coopey V Wright M Short C Casey J Goff **ADDRESS:** 59 Greathead Crescent Newton Aycliffe Co. Durham DL5 5DP **CHARITY NUMBER:** 1188444 **ACCOUNTANTS:** TC Group The Greenhouse Amos Drive, Greencroft Industrial Estate Annfield Plain Co. Durham DN9 7XN 

Page 1 



## **Great Aycliffe Cancer Support** 

## **Report of the Trustees for the Year Ended 31 December 2025** 

The trustees present their report with the financial statements of the charity for the year ended 31 December 2025. 

## **TRUSTEES** 

The trustees shown below have held office during the whole of the year to the date of this report. 

A White V Moody D Morris A Coopey V Wright M Short C Casey J Goff 

## **OBJECTIVES OF THE CHARITY** 

The Charity was registered on the 10 March 2020 to give assistance to members of the public who were suffering from or who had suffered from cancer. The assistance extended to their families and carers, 

The assistance can take the form of financial help, advice and companionship, transport to hospital and other medical appointments and short holidays in the charity’s caravan. 

## **ACHIEVEMENTS AND PERFORMANCE** 

The trustees are pleased to report that the objectives have continued to be achieved, partly through the donation and grants received and with the help of a number of volunteer drivers whose help has been most gratefully received. 

The charity’s largest expense remains as patient transport, due to the reimbursement of volunteer drivers fuel costs. The continuing fluctuations in fuel price make this a particularly challenging area. Patient support is another significant cost, which can take the form of meetings, outings, one to one advice, hampers and generally providing help where necessary. 

The charity has continued to provide a caravan for short breaks for patients and carers and this service has proved invaluable to those that have utilised it. During the year the charity acquired a second caravan and has been able to increase the availability for short breaks for patients. 

The charity is run by the trustees who meet once per month to discuss matters. 

## **RISK ASSESSMENT** 

The main risk which the charity faces is that of reduction in income, due to the downturn in the economy. As this is outside the control of the charity, the only action that can be taken is to build up sufficient reserves. 

## **RESERVES** 

The trustees have decided to build up a reserve equivalent to approximately one year's gross cost of transportation. This is estimated to be currently running at about £30,000 and rising. 

The trustees declare that they have approved the trustees’ report above. 

## **ON BEHALF OF THE CHARITY’S TRUSTEES:** 

Al1ison White – Chair of the Board of Trustees 

Date: 29 October 2026 

Page 2 



## **Great Aycliffe Cancer Support Independent Examiners Report to the Trustees of Great Aycliffe Cancer Support** 

I report on the accounts of Great Aycliffe Cancer Support for the year ended 31 December 2025 set out on pages 2 to 8. 

## **Respective responsibilities of trustees and independent examiner** 

The charity’s trustees are responsible for the preparation of the accounts. The trustees consider that an audit is not required for the year under section 144 of the Charities Act 2011 (the Charities Act) and that an independent examination is needed. 

It is my responsibility to: 

- examine the accounts under section 145 of the Charities Act, 

- to follow the procedures laid down in the general Directions given by the Charity Commission (under section 145(5)(b) of the Charities Act), and 

- to state whether particular matters have come to my attention. 

## **Basis of independent examiner’s statement** 

My examination was carried out in accordance with general Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from the trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the accounts present a ‘true and fair’ view and the report is limited to those matters set out in the statement below. 

## **Independent examiner’s statement** 

In connection with my examination, no matter has come to my attention: 

1. which gives me reasonable cause to believe that in, any material respect, the requirements - to keep accounting records in accordance with section 130 of the Charities Act; 

- to prepare accounts which accord with the accounting records and comply with the accounting requirements of the Charities Act have not been met; or 

2. to which, in my opinion, attention should be drawn in order to enable a proper understanding of the accounts to be reached. 

TC Group The Greenhouse Amos Drive, Greencroft Industrial Estate Annfield Plain Stanley Co. Durham DH9 7XN 

Date: 29 October 2026 

Page 3 



## **Great Aycliffe Cancer Support Statement of Financial Activities Year Ended 31 December 2025** 

|**INCOME**<br>**Grants and Donations**<br>**Income from charitable activities:**<br>Fundraising & Sales<br>**Total income**<br>**EXPENDITURE**<br>**Charitable Activities**<br>**Other Expenditure**<br>**Total expenditure**<br>**Net income and net movement in**<br>**funds for the year**<br>**Transfer between funds**<br>**Reconciliation of funds**<br>Total funds brought forward<br>**Total funds carried forward**|**Notes**<br>2<br>3<br>4<br>4<br>4<br>7<br>7|**Unrestricted**<br>**Funds**<br>**60,371**<br>**40,179**<br>**100,550**<br>**125,300**<br>**180**<br>**125,480**<br>**(24,930)**<br>**-**<br>**81,731**<br>**56,801**|**Restricted**<br>**Funds**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,000**<br>**1,000**|**Total**<br>**2025**<br>**60,371**<br>**40,179**<br>**100,550**<br>**125,300**<br>**180**<br>**125,480**<br>**(24,930)**<br>**-**<br>**82,731**<br>**57,801**|**Total**<br>**2024**<br>**72,242**<br>**43,669**<br>**115,911**<br>**104,456**<br>**180**<br>**104,636**<br>**11,275**<br>**-**<br>**71,456**<br>**82,731**|
|---|---|---|---|---|---|



Page 4 



## **Great Aycliffe Cancer Support Balance Sheet Year Ended 31 December 2025** 

|**Notes**<br>**FIXED ASSETS**<br>Tangible assets<br>5<br>**Total Fixed Assets**<br>**CURRENT ASSETS**<br>Cash at bank<br>**Total Current Assets**<br>**Creditors Amounts falling due**<br>**within one year**<br>6<br>**Net Current Assets**<br>**Total assets less current liabilities**<br>**Creditors: Amounts falling due**<br>**after more than one year**<br>**Net assets**<br>**Funds**<br>Restricted<br>Unrestricted<br>7<br>**Total charity funds**|**Unrestricted**<br>**27,145**<br>**27,145**<br>**38,336**<br>**38,336**<br>**(8,680)**<br>**29,656**<br>**56,801**<br>**-**<br>**56,801**<br>**-**<br>**56,801**<br>**56,801**|**Restricted**<br>**-**<br>**-**<br>**1,000**<br>**1,000**<br>**-**<br>**1,000**<br>**1,000**<br>**-**<br>**1,000**<br>**1,000**<br>**-**<br>**1,000**|**2025**<br>**Total**<br>**27,145**<br>**27,145**<br>**39,336**<br>**39,336**<br>**(8,680)**<br>**30,656**<br>**57,801**<br>**-**<br>**57,801**<br>**1,000**<br>**56,801**<br>**57,801**|**2024**<br>**Total**<br>**21,567**<br>**21,567**<br>**61,344**<br>**61,344**<br>**(180)**<br>**61,164**<br>**82,731**<br>**-**<br>**82,731**<br>**1,000**<br>**81,731**<br>**82,731**|
|---|---|---|---|---|



The financial statements were approved by the trustees on 29 October 2026 and were signed on its behalf by: 

Allison White – Chair of the Board of Trustees 

Page 5 



**Great Aycliffe Cancer Support Notes to the Financial Statements for the Year Ended 31 December 2025** 

## **1. ACCOUNTING POLICIES** 

## **Accounting convention** 

The financial statements have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant notes to these accounts. 

The accounts have been prepared in accordance with the  Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and  Republic of Ireland (FRS 102) (effective 1 January 2015) - (Charities SORP (FRS 102)) and the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) 

## **Fund accounting** 

Unrestricted funds are general funds which are for use at the discretion of the trustees in furtherance of the general objectives of the charity. 

Restricted funds are funds to be used in accordance with specific restrictions imposed by donors.  Any balance remaining unspent at the end of the year must be carried forward as a balance on that fund. 

## **Incoming Resources** 

All incoming resources are included in the statement of financial activities when the charity is entitled to the income and the amount can be quantified with reasonable accuracy. 

## **Voluntary Income** 

Voluntary Income is received by way of grants and donation and is included in the financial statements when the charity is legally entitled to the income and the amount can be quantified with reasonable accuracy. 

## **Governance Costs** 

Governance costs include those costs associated with meeting the constitutional and statutory requirements of the charity and include accountancy fees and costs related to the strategic management of the charity. 

## **Tangible fixed assets** 

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is shorter. 

Caravan -   10% straight line 

## **Debtors** 

Trade Debtors and other debtors are recognised at the settlement amount due after any trade discount offered.  Prepayments are valued at the amount prepaid net of any trade discount due 

## **Creditors and provisions** 

Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably.  Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discount due. 

Page 6 



## **Great Aycliffe Cancer Support Notes to the Financial Statements for the Year Ended 31 December 2025** 

|**2.**<br>**Grants and Donations**<br>Grants receivable<br>Donations<br>**3.**<br>**Incoming  from charitable activities:**<br>Fundraising<br>Sales<br>**4.**<br>**Expenditure**<br>**Costs directly allocated to activities**<br>Cost of sales<br>Electricity<br>Fundraising costs<br>Patient support<br>Patient transport<br>Caravan costs<br>Rent<br>Depreciation<br>Repairs & maintenance<br>Telephone<br>Printing, postage & stationery<br>Loss on disposal on caravan<br>Professional fees|**Charitable**<br>**Activities**<br>**Unrestricted**<br>**£**<br>**-**<br>**1000**<br>**11,684**<br>**15,545**<br>**56,728**<br>**14,615**<br>**6,324**<br>**4,790**<br>**2,773**<br>**886**<br>**1,263**<br>**9,692**<br>**-**<br>**125,300**|**Unrestricted**<br>**Funds**<br>**£**<br>**3,000**<br>**57,371**<br>**60,371**<br>**Charitable**<br>**Activities**<br>**Restricted**<br>**£**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Restricted**<br>**funds**<br>**£**<br>**-**<br>**-**<br>**-**<br>**Unrestricted**<br>**Funds**<br>**£**<br>**-**<br>**40,179**<br>**40,179**<br>**Governance**<br>**£**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**180**<br>**180**|**Total**<br>**2025**<br>**£**<br>**3,000**<br>**57,371**<br>**60,371**<br>**Total**<br>**2025**<br>**£**<br>**-**<br>**40,179**<br>**40,179**<br>**Total**<br>**2025**<br>**£**<br>**-**<br>**1000**<br>**11,684**<br>**15,545**<br>**56,728**<br>**14,615**<br>**6,324**<br>**4,790**<br>**2,773**<br>**886**<br>**1,263**<br>**9,692**<br>**180**<br>**125,480**|**Total**<br>**2024**<br>**£**<br>**6,500**<br>**65,742**<br>**72,242**<br>**Total**<br>**2024**<br>**£**<br>**-**<br>**43,669**<br>**43,669**<br>**Total**<br>**2024**<br>**£**<br>**-**<br>**-**<br>**11,053**<br>**10,683**<br>**54,762**<br>**10,491**<br>**3,156**<br>**2695**<br>**7,984**<br>**2,348**<br>**1,284**<br>**-**<br>**180**<br>**104,636**|
|---|---|---|---|---|---|



Page 7 



## **Great Aycliffe Cancer Support Notes to the Financial Statements for the Year Ended 31 December 2025** 

## **5. TANGIBLE FIXED ASSETS** 

|**COST**<br>At 1 January 2025<br>Additions<br>Disposals<br>At 31 December 2025<br>**DEPRECIATION**<br>At 1 January 2025<br>Charge for year<br>Eliminated on disposal<br>At 31 December 2025<br>**NET BOOK VALUE**<br>At 31 December 2025<br>At 31 December 2024<br>**6.**<br>**CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**<br>Other creditors<br>Other loans<br>**7.**<br>**FUND MOVEMENTS**<br>**Balance at**<br>**Incoming**<br>**Outgoing**<br>**1 January**<br>**resources**<br>**resources**<br>**2025**<br>**£**<br>**£**<br>**£**<br>**Restricted**<br>**1,000**<br>**-**<br>**-**<br>**Unrestricted**<br>General Funds<br>**81,731**<br>**100,550**<br>**(125,480)**<br>**TOTAL FUNDS**<br>**82,731**<br>**100,550**<br>**(125,480)**|**Caravan**<br>**£**<br>**26,957**<br>**31,935**<br>**(26,957)**<br>**31,935**<br>**5,390**<br>**4,790**<br>**(5,390)**<br>**4,790**<br>**27,145**<br>**21,567**<br>**Total**<br>**2025**<br>**£**<br>**180**<br>**8,500**<br>**8,680**<br>**Transfers**<br>**£**<br>**-**<br>**-**<br>**-**|**Totals**<br>**£**<br>**26,957**<br>**31,935**<br>**(26,957)**<br>**31,935**<br>**5,390**<br>**4,790**<br>**(5,390)**<br>**4,790**<br>**27,145**<br>**21,567**<br>**Total**<br>**2024**<br>**£**<br>**180**<br>**-**<br>**180**<br>**Balance at**<br>**31 December**<br>**2024**<br>**£**<br>**1,000**<br>**56,801**<br>**57,801**|
|---|---|---|



## **8. ANALYSIS OF NET ASSETS** 

|**Restricted**<br>**Unrestricted**|**Tangible**<br>**Fixed**<br>**Assets**<br>**£**<br>**-**<br>**-**<br>**-**|**Other Net**<br>**Assets**<br>**£**<br>**1,000**<br>**56,801**<br>**57,801**|
|---|---|---|



Page 8 

